Free Trial

Fractyl Health (GUTS) Competitors

Fractyl Health logo
$1.33 -0.02 (-1.48%)
Closing price 10/15/2025 04:00 PM Eastern
Extended Trading
$1.36 +0.02 (+1.88%)
As of 07:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GUTS vs. BWAY, SMTI, OM, MGRM, SI, INGN, TLSI, CVRX, NNOX, and CV

Should you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Brainsway (BWAY), Sanara MedTech (SMTI), Outset Medical (OM), Monogram Orthopaedics (MGRM), Shoulder Innovations (SI), Inogen (INGN), TriSalus Life Sciences (TLSI), CVRx (CVRX), Nano-X Imaging (NNOX), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.

Fractyl Health vs. Its Competitors

Brainsway (NASDAQ:BWAY) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

Brainsway has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Comparatively, Fractyl Health has a beta of 2.27, indicating that its share price is 127% more volatile than the S&P 500.

Brainsway currently has a consensus target price of $18.00, suggesting a potential upside of 12.50%. Fractyl Health has a consensus target price of $6.90, suggesting a potential upside of 418.80%. Given Fractyl Health's higher probable upside, analysts clearly believe Fractyl Health is more favorable than Brainsway.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Brainsway
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Fractyl Health
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

Brainsway has a net margin of 11.60% compared to Fractyl Health's net margin of 0.00%. Brainsway's return on equity of 8.97% beat Fractyl Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Brainsway11.60% 8.97% 5.65%
Fractyl Health N/A -584.35%-102.88%

30.1% of Brainsway shares are held by institutional investors. 19.0% of Brainsway shares are held by company insiders. Comparatively, 26.1% of Fractyl Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Brainsway had 3 more articles in the media than Fractyl Health. MarketBeat recorded 4 mentions for Brainsway and 1 mentions for Fractyl Health. Brainsway's average media sentiment score of 0.63 beat Fractyl Health's score of 0.62 indicating that Brainsway is being referred to more favorably in the media.

Company Overall Sentiment
Brainsway Positive
Fractyl Health Positive

Brainsway has higher revenue and earnings than Fractyl Health. Fractyl Health is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brainsway$46.08M6.60$2.92M$0.2661.54
Fractyl Health$17K3,934.37-$68.69M-$2.06-0.65

Summary

Brainsway beats Fractyl Health on 11 of the 16 factors compared between the two stocks.

Get Fractyl Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GUTS vs. The Competition

MetricFractyl HealthMED IndustryMedical SectorNASDAQ Exchange
Market Cap$67.89M$2.96B$6.12B$10.45B
Dividend YieldN/A57.77%5.73%4.77%
P/E Ratio-0.6522.7985.3327.36
Price / Sales3,934.37778.19601.99136.95
Price / CashN/A172.6337.4661.86
Price / Book2.255.5112.566.81
Net Income-$68.69M$33.06M$3.32B$276.80M
7 Day Performance-5.00%0.23%0.59%0.42%
1 Month Performance33.70%14.73%10.52%7.86%
1 Year Performance-46.15%-1.42%75.05%41.24%

Fractyl Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GUTS
Fractyl Health
3.208 of 5 stars
$1.33
-1.5%
$6.90
+418.8%
-43.9%$67.89M$17K-0.65102Gap Up
BWAY
Brainsway
3.0422 of 5 stars
$15.23
-0.5%
$18.00
+18.2%
+71.7%$290.47M$41.02M58.58120Analyst Forecast
SMTI
Sanara MedTech
2.6083 of 5 stars
$31.26
+0.2%
$50.00
+59.9%
-7.0%$277.66M$86.67M-26.9560High Trading Volume
OM
Outset Medical
1.8204 of 5 stars
$14.88
+2.7%
$24.67
+65.8%
+48.3%$257.43M$113.69M-0.73520News Coverage
High Trading Volume
MGRM
Monogram Orthopaedics
1.1997 of 5 stars
$6.00
-1.8%
$5.40
-10.0%
N/A$248.26M$370K-12.0028Positive News
High Trading Volume
SI
Shoulder Innovations
3.2164 of 5 stars
$13.21
+8.4%
$19.60
+48.4%
N/A$248.19M$37.32M-0.4461
INGN
Inogen
4.0207 of 5 stars
$8.43
-2.5%
$11.00
+30.5%
-7.9%$233.90M$335.70M-7.951,030Analyst Forecast
TLSI
TriSalus Life Sciences
2.5783 of 5 stars
$4.63
+0.2%
$10.90
+135.4%
+1.8%$230.39M$29.43M-3.92106News Coverage
CVRX
CVRx
2.5265 of 5 stars
$8.73
+0.2%
$14.00
+60.4%
+20.0%$227.78M$51.29M-4.16160
NNOX
Nano-X Imaging
2.6737 of 5 stars
$4.13
+5.1%
$8.50
+105.8%
-29.3%$227.07M$11.28M-4.59190
CV
CapsoVision
N/A$4.57
-4.6%
$5.50
+20.4%
N/A$224.05MN/A0.0090

Related Companies and Tools


This page (NASDAQ:GUTS) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners